A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-TB. Through innovative partnerships and collaborations, Johnson & Johnson is working to create world without DR-TB and end TB.
- Home
- Our company
- Social impact
- Global health equity
- It’s time to end drug-resistant tuberculosis: The case for action
It’s time to end drug-resistant tuberculosis: The case for action
- X (Twitter)
Copy link